416 related articles for article (PubMed ID: 22198775)
1. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy.
Vosskuhl K; Negm AA; Framke T; Weismüller T; Manns MP; Wedemeyer H; Plentz RR; Wedemeyer J; Lankisch TO
Endoscopy; 2012 Jan; 44(1):48-52. PubMed ID: 22198775
[TBL] [Abstract][Full Text] [Related]
2. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
[TBL] [Abstract][Full Text] [Related]
4. IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma.
Nguyen-tat M; Gamstätter T; Marquardt JU; Geißinger E; Schadmand-Fischer S; Lang H; Siegel E; Schuchmann M; Galle PR; Wörns MA
Z Gastroenterol; 2012 Sep; 50(9):1008-12. PubMed ID: 22965631
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease.
Alderlieste YA; van den Elzen BD; Rauws EA; Beuers U
Digestion; 2009; 79(4):220-8. PubMed ID: 19390194
[TBL] [Abstract][Full Text] [Related]
6. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.
Oseini AM; Chaiteerakij R; Shire AM; Ghazale A; Kaiya J; Moser CD; Aderca I; Mettler TA; Therneau TM; Zhang L; Takahashi N; Chari ST; Roberts LR
Hepatology; 2011 Sep; 54(3):940-8. PubMed ID: 21674559
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
[TBL] [Abstract][Full Text] [Related]
10. [IgG4 associated autoimmune cholangitis].
Färkkilä M
Duodecim; 2011; 127(1):49-55. PubMed ID: 21442874
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune cholangitis and cholangiocarcinoma.
Li J; Zhao C; Shen Y
J Gastroenterol Hepatol; 2012 Dec; 27(12):1783-9. PubMed ID: 23034143
[TBL] [Abstract][Full Text] [Related]
12. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
13. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
14. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
Lankisch TO; Metzger J; Negm AA; Vosskuhl K; Schiffer E; Siwy J; Weismüller TJ; Schneider AS; Thedieck K; Baumeister R; Zürbig P; Weissinger EM; Manns MP; Mischak H; Wedemeyer J
Hepatology; 2011 Mar; 53(3):875-84. PubMed ID: 21374660
[TBL] [Abstract][Full Text] [Related]
15. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.
Metzger J; Negm AA; Plentz RR; Weismüller TJ; Wedemeyer J; Karlsen TH; Dakna M; Mullen W; Mischak H; Manns MP; Lankisch TO
Gut; 2013 Jan; 62(1):122-30. PubMed ID: 22580416
[TBL] [Abstract][Full Text] [Related]
16. IgG4-associated cholangitis.
Nath V; Lewin J; Subramony C; Shenoy V
J Miss State Med Assoc; 2014 Dec; 55(12):384-8. PubMed ID: 25799760
[TBL] [Abstract][Full Text] [Related]
17. A case of IgG4-related sclerosing cholangitis mimicking an intrahepatic cholangiocellular carcinoma.
Maeda M; Shimada K
Jpn J Clin Oncol; 2012 Feb; 42(2):153. PubMed ID: 22291208
[No Abstract] [Full Text] [Related]
18. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Lin J; Cummings OW; Greenson JK; House MG; Liu X; Nalbantoglu I; Pai R; Davidson DD; Reuss SA
Scand J Gastroenterol; 2015 Apr; 50(4):447-53. PubMed ID: 25635498
[TBL] [Abstract][Full Text] [Related]
19. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma.
Resheq YJ; Quaas A; von Renteln D; Schramm C; Lohse AW; Lüth S
Dig Liver Dis; 2013 Oct; 45(10):859-65. PubMed ID: 23602806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
